Why is metabolic syndrome so important if it's not a disease? What have we learned from clinical trials about treating metabolic syndrome with lifestyle and/or drugs? And, what hurdles does the clinician face in trying to improve metabolic syndrome variables in the individual patient? Join Host Dr. Alan Brown as he welcomes Dr. Neil J Stone who will answer these questions and more. Dr. Stone is the Bonow Professor of Medicine at The Feinberg School of Medicine of Northwestern University and Distinguished Physician and Medical Director of the Vascular Center of the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital in Chicago, Illinois.
Non-pharmacologic Approaches to the Metabolic Syndrome and Diabetes

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Why is metabolic syndrome so important if it's not a disease? What have we learned from clinical trials about treating metabolic syndrome with lifestyle and/or drugs? And, what hurdles does the clinician face in trying to improve metabolic syndrome variables in the individual patient? Join Host Dr. Alan Brown as he welcomes Dr. Neil J Stone who will answer these questions and more. Dr. Stone is the Bonow Professor of Medicine at The Feinberg School of Medicine of Northwestern University and Distinguished Physician and Medical Director of the Vascular Center of the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital in Chicago, Illinois.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Digital Therapeutics Clinical Trials: From Design to Data Interpretation
Engaging Patients and Caregivers About Digital Therapeutics
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
Personalizing Care Within the RCC Treatment Paradigm
Understanding hypertrophic cardiomyopathy and recent guidelines
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?